Zydus had approached the Supreme Court challenging the Delhi High Court’s order, which prevented the company from producing and marketing breast cancer drug Sigrima.
Your email address will not be published. Required fields are marked *
Name*
Email*
Website
Save my name, email, and website in this browser for the next time I comment.